CV Sciences Inc (OTCMKTS: CVSI) is one of the best known CBD stocks trading on the OTC Markets. The company makes a popular form of chewing gum and its CBD oil is currently the highest-quality top-selling brand, with an excellent reputation for product safety and efficiency.
So far this year, this popularity has not translated into a top-performing stock. For most of 2019, CVSI has been range-bound, whereas in 2018 we saw the stock run from $1 to $9 in just 4 months. Investors are now asking if we are going to see another explosive move this summer?
First up, here’s a little background info for those of you that aren’t familiar with CVSI. CV Sciences, Inc. operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing novel therapeutics utilizing CBD. The Company’s PlusCBD Oil™ is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada.
Deloitte & Touche LLP As Auditor
The big expectation we have here at MJ Global Report is that CVSI is going to uplist to NASDAQ. This is why the company has hired the big accounting firm of Deloitte & Touche LLP as the Company’s new independent registered public accounting firm. Having a prestigious accounting firm as your auditor helps when it comes to NASDAQ listing. We believe it’s not if, but when CVSI will be trading on the NASDAQ.
Earnings Next Week
The next big catalyst for the stock will be when CV Sciences reports its first quarter of 2019 ended March 31, 2019, after the stock market closes on Wednesday, May 8, 2019. The Company will also hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day.
New Distribution Channels
Last month, CV Sciences announced further expansion of its industry-dominating brand, PlusCBD Oil™. As of March 31, 2019, PlusCBD Oil
“The passage of the 2018 Farm Bill has accelerated our business development activities and expanded our distribution to new food, drug, mass merchandise retailers. We are at an important stage in the development of the hemp-based CBD market, and the company is well-positioned to capitalize on both growing consumer demand and the benefit of enhanced regulation that supports and ensures the safest and highest quality hemp-based CBD products for consumers.”
Currently trading with a market cap of $500 million, CVSI is one of the most exciting stories among CBD stocks. With what many consider the best CBD oil in the business and growing demand for all things CBD, we believe CVSI is one of the best long-term plays for investors looking for exposure to the CBD space. We expect the stock to breakout higher much sooner than later.
For the latest updates on CVSI and other CBD stocks, sign up below!
Disclosure: We have no position in CVSI and have not been compensated for this article.
Image courtesy of Pexels
Can Isodiol International Inc (CNSX:ISOL)(OTCMKTS:ISOLF) Break Out From Here?
Investors have jumped on Isodiol International Inc (CNSX:ISOL)(OTCMKTS:ISOLF) stock this month. The stock gained 62% on January 21, marking its best day so far in 2020. The stock has already gained 106% year-to-date. But do not think even for a minute that investors have warmed up to Isodiol stock for nothing. This is a stock with tremendous potential and at this point, the stock is just showing early signs of what is going to be a big breakout.
In case you are wondering why investors have started jostling for a piece of Isodiol early on in the year, this report answers that question and more. But before we delve into the details, it is important to first understand the company we’re discussing here.
About Isodiol International
Isodiol International is a Canadian company that has specialized in the making of pharmaceutical and consumer products derived from hemp. It makes CBD products derived from hemp grown and processed in the United States. Though Isodiol’s operations are currently concentrated in North America, the company has big expansion dreams. It has set its sights on expanding into Latin America, Asia, and Europe.
What exactly is drawing investors to Isodiol stock and why does it stand out as a good pick in the hemp/cannabis stock universe in 2020? The simple answer is that investors are beginning to realize Isodiol’s bright prospects as a CBD products company.
Isodiol bidding for…
New Age Beverage (NASDAQ:NBEV) Solid Fundamentals Amidst Price Slump
New Age Beverage (NASDAQ:NBEV) has taken a significant beating since the start of the year. A 60% plus slide attests to a stock under immense pressure. Amidst the underperformance in the stock market, the company has continued to do exceedingly well when it comes to core business execution and operation efficiency.
New Age Beverage Catalysts And Price Analysis
Triple-digit revenue growth is one of the developments that continues to affirm the company’s long-term prospects. The company also remains well-positioned to generate bottom-line growth backed by robust retail channels in the U.S as well as expansion in Asia. Integration of Morinda operations in China is another development likely to continue strengthening the company’s bottom line going forward.
A spike in implied volatility in the options market is the latest development that signals a potential turnaround in the direction of trade. Huge implied volatility indicates that trade is developing. What is clear is that the stock has taken a significant hit and may be due for a correction higher, given the improving fundamentals.
Increased activity around the $2.50 Put options could signal a potential change in the direction of trade. After the recent slide lower, the stock needs to rise and find support above the $2.40 resistance level. A rally past the $2.40 level should reaffirm New Age Beverages bounce back prospects.
Above the crucial resistance level, the stock should be on its way to the…
Charlotte’s Web Stock (TSE:CWEB) (OTCMKTS:CWBHF) Poised For Breakout And Here’s Why
Charlotte’s Web Stock (TSE:CWEB) (OTCMKTS:CWBHF) is currently at one of its lowest price levels in about five months. That is the result of a selloff that kicked off toward late September after the stock reached one of its highest watermarks at $23 in August.
You cannot rule out profit-taking as having contributed to the decline that has brought the stock to its current lows considering the stock pulled up from one of its lowest levels this year in July before the August breakout. A repeat of the August bull run that powered CWBHF to one of its highest price levels this year seems to be in the offing.
Firstly, after a string of declines for much of last week and early this week, CWBHF has begun showing signs of a comeback. The stock closed the last session (November 5), up. Now the stock has found immediate support at $10.9 from where it looks set for a powerful breakout as happened in March, June, and July.
In March, for instance, CWBHF bolted from a low of $13 on March 8 to reach its one-year peak of $25 in a space of fewer than 30 days on April 4. Profit-taking kicked off after that and the stock fell to around $10 in mid-June, from where it began rising again, topping $18.5 in early July. Investors again took profit and toward late July the stock was back down at around $13.5.…